Just months after it started trading on the Nasdaq in June 2021, the company was valued as high as $5.8 billion. As of Friday, the firm’s shares were worth less than a dollar.

It also provides a relatively straightforward way for customers to delete their data and request that their genetic samples be destroyed. "If, at any time, you are no longer interested in ...

The tissue sample is permeabilized just before being placed on ... They then assembled the clones into a phylogenetic hierarchy to chart how the cells’ genetic composition had changed over time.